Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,730.00
Bid: 2,726.00
Ask: 2,728.00
Change: 18.00 (0.66%)
Spread: 2.00 (0.073%)
Open: 2,706.00
High: 2,734.00
Low: 2,706.00
Prev. Close: 2,712.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

16 Jun 2020 13:06

RNS Number : 1359Q
Coca-Cola HBC AG
16 June 2020
 

 

FOR IMMEDIATE RELEASE

Coca-Cola HBC AG

Results of Annual General Meeting of Coca-Cola HBC AG and election of Ms. Anna Diamantopoulou as a new Member of the Board of Directors

 

 

Zug, Switzerland - 16 June 2020 - Coca-Cola HBC AG ("Coca-Cola HBC") today announces that all of the proposals of the Board of Directors (the "Board") set out in the notice of the annual general meeting ("AGM") dated 14 May 2020 were duly passed by the requisite majority of shareholders at its AGM held today, 16 June 2020. The final results are set out below. A copy of the resolutions passed at the AGM has also been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on Coca-Cola HBC's website at www.coca-colahellenic.com

 

Coca-Cola HBC's shareholders elected Ms. Anna Diamantopoulou as a new member of the Board. Her biography can be found at www.coca-colahellenic.com

 

The AGM approved a dividend of EUR 0.62 per share ("Dividend") out of the general capital contribution reserve, capped at an amount of CHF 300,000,000. Payment of the full amount of the Dividend will be made on 28 July 2020 to holders of ordinary shares on the record date of 3 July 2020. The shares are expected to be traded ex-dividend as of 2 July 2020, in which case the last day on which the shares may be traded with the entitlement to receive dividends will be 1 July 2020. In addition, the AGM approved a share buy back of up to up to 10,000,000 ordinary shares of CHF 6.70.

 

Final Ballot Results

 

Proposal

Votes

for

%

(1)

Votes Against

%

(1)

Abs-

tentions Cast

%

(1)

Total Votes Cast

Votes not cast (2)

Voting Rights Repre-

sented % (3)

1.

Receipt of the 2019 Integrated Annual Report, as well as approval of the annual management report, the stand-alone financial statements and the consolidated financial statements

268113726

99.91%

9374

0.01%

207013

0.08%

268330113

0

73.70%

2.1.

Appropriation of available earnings

267914411

99.84%

342319

0.13%

73383

0.03%

268330113

0

73.70%

2.2.

Declaration of dividends from reserves

267869664

99.83%

342419

0.13%

118030

0.04%

268330113

0

73.70%

3.

Discharge of the members of the Board of Directors and the members of the Operating Committee

267291138

99.61%

773201

0.29%

265774

0.10%

268330113

0

73.70%

4.1.1.

Re-election of Anastassis G. David as a member of the Board of Directors and as the Chairman of the Board of Directors

253318388

94.41%

13100559

4.88%

1911166

0.71%

268330113

0

73.70%

 

 

4.1.2.

Re-election of Zoran Bogdanovic as a member of the Board of Directors

265654637

99.00%

2600593

0.97%

74883

0.03%

268330113

0

73.70%

4.1.3.

Re-election of Charlotte J. Boyle as a member of the Board of Directors and as a member of the Remuneration Committee

266641168

99.37%

1613126

0.60%

75819

0.03%

268330113

0

73.70%

4.1.4.

Re-election of Reto Francioni as a member of the Board of Directors and as a member of the Remuneration Committee

261089665

97.30%

7164629

2.67%

75819

0.03%

268330113

0

73.70%

4.1.5.

Re-election of Olusola David-Borha as a member of the Board of Directors

267615601

99.73%

639629

0.24%

74883

0.03%

268330113

0

73.70%

4.1.6.

Re-election of William W. Douglas III as a member of the Board of Directors

264913584

98.72%

3340710

1.25%

75819

0.03%

268330113

0

73.70%

4.1.7.

Re-election of Anastasios I. Leventis as a member of the Board of Directors

260883393

97.22%

7373337

2.75%

73383

0.03%

268330113

0

73.70%

4.1.8.

Re-election of Christodoulos Leventis as a member of the Board of Directors

260931101

97.24%

7325629

2.73%

73383

0.03%

268330113

0

73.70%

4.1.9.

Re-election of Alexandra Papalexopoulou as a member of the Board of Directors

266221934

99.21%

2034796

0.76%

73383

0.03%

268330113

0

73.70%

4.1.10.

Re-election of José Octavio Reyes as a member of the Board of Directors

260928288

97.24%

7186935

2.68%

214890

0.08%

268330113

0

73.70%

4.1.11.

Re-election of Alfredo Rivera as a member of the Board of Directors

259175697

96.59%

8934059

3.33%

220357

0.08%

268330113

0

73.70%

4.1.12.

Re-election of Ryan Rudolph as a member of the Board of Directors

260754467

97.17%

7499827

2.80%

75819

0.03%

268330113

0

73.70%

4.2.

Election of Anna Diamantopoulou as a new member of the Board of Directors and as a new member of the Remuneration Committee

267859645

99.82%

394439

0.15%

76029

0.03%

268330113

0

73.70%

5.

Election of the independent proxy

266385199

99.27%

1870331

0.70%

74583

0.03%

268330113

0

73.70%

6.1.

Re-election of the statutory auditor

264612676

98.62%

3597857

1.34%

119580

0.04%

268330113

0

73.70%

6.2.

Advisory vote on re-appointment of the independent registered public accounting firm for UK purposes

266544842

99.33%

1708237

0.64%

77034

0.03%

268330113

0

73.70%

7.

Advisory vote on the UK Remuneration Report

261130154

97.32%

5744287

2.14%

1455672

0.54%

268330113

0

73.70%

8.

Advisory vote on the Remuneration Policy

251002866

93.54%

17250378

6.43%

76869

0.03%

268330113

0

73.70%

9.

Advisory vote on the Swiss Remuneration Report

261453104

97.44%

6799039

2.53%

77970

0.03%

268330113

0

73.70%

10.1.

Approval of the maximum aggregate amount of remuneration for the Board of Directors until the next annual general meeting

267895965

99.87%

347298

0.13%

86850

n.a.

268243263

0

73.70%

10.2.

Approval of the maximum aggregate amount of remuneration for the Operating Committee for the next financial year

265205431

99.38%

1660130

0.62%

1464552

n.a.

266865561

0

73.70%

11.

Approval of share buy-back

265309621

98.88%

2933228

1.09%

87264

0.03%

268330113

0

73.70%

 

(1) Percentages refer to applicable majority. Proposals 1-9 require approval by an absolute majority of the votes validly cast (including consenting and dissenting votes and abstentions). Proposals 10.1 and 10.2 require approval by a relative majority of the votes validly cast (including consenting and dissenting votes without abstentions). Proposal 11 requires approval by an absolute majority of the votes validly cast (including consenting and dissenting votes and abstentions).

 

(2) Votes represented at the AGM but not (or not validly) cast.

 

(3) Shares represented at the AGM for each proposal as a percentage of Coca-Cola HBC's outstanding voting rights, whether exercisable or not. As at the date of the AGM, Coca-Cola HBC's issued share capital consisted of 370'251'684 ordinary shares, of which 2'759'280 ordinary shares are held by Coca-Cola HBC AG and 3'430'135 shares are held by its subsidiary, COCA-COLA HBC SERVICES MEPE, in treasury. Accordingly, the total number of outstanding voting rights (whether exercisable or not) in Coca-Cola HBC AG was 364'062'269.

 

 

 

Enquiries

Coca‑Cola HBC Group

Investors and Analysts:

 

Joanna Kennedy

Investor Relations Director

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

 

 

Carla Fabiano

Investor Relations Manager

Tel: +44 20 37 444 231

carla.fabiano@cchellenic.com

 

 

 

 

Media:

 

 

David Hart

Group Communication Director

Tel: +41 41 726 0143

 david.hart@cchellenic.com

 

 

 

International media contact:

Teneo

Rob Morgan

Tom Davies

Tel: +44 7557 413 275

robert.morgan@teneo.com

tom.davies@teneo.com

 

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

ao@vando.gr

 

 

 

      

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with 2019 revenue in excess of €7 billion. It has a broad geographic footprint with operations in 28 countries serving a population of more than 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, plant based beverages and ready-to-drink tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good, among others.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGEAAKKFEAEEFA
Date   Source Headline
8th May 20245:50 pmRNSTransaction in Own Shares
7th May 20245:29 pmRNSTransaction in Own Shares
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement
22nd Mar 20245:05 pmRNSTransaction in Own Shares
21st Mar 20245:40 pmRNSTransaction in Own Shares
20th Mar 20245:33 pmRNSTransaction in Own Shares
19th Mar 20245:20 pmRNSTransaction in Own Shares
19th Mar 20241:19 pmRNSDirector/PDMR Shareholding
18th Mar 20245:20 pmRNSTransaction in Own Shares
15th Mar 20246:25 pmRNSTransaction in Own Shares
15th Mar 20245:58 pmRNSAnnual Financial Report
14th Mar 20245:30 pmRNSTransaction in Own Shares
14th Mar 20243:04 pmRNSDirector/PDMR Shareholding
14th Mar 20242:56 pmRNSDirector/PDMR Shareholding
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:15 pmRNSTransaction in Own Shares
11th Mar 20245:50 pmRNSTransaction in Own Shares
8th Mar 20245:45 pmRNSTransaction in Own Shares
7th Mar 20245:20 pmRNSTransaction in Own Shares
6th Mar 20245:10 pmRNSTransaction in Own Shares
5th Mar 20245:15 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares
1st Mar 20245:15 pmRNSTransaction in Own Shares
1st Mar 20249:25 amRNSIssue of Equity and total voting rights
29th Feb 20245:25 pmRNSTransaction in Own Shares
29th Feb 20243:10 pmRNSDirector/PDMR Shareholding
29th Feb 20243:00 pmRNSDirector/PDMR Shareholding
29th Feb 20242:53 pmRNSDirector/PDMR Shareholding
28th Feb 20245:25 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.